UPDATE 1-Amgen's cancer drug meets main goal in late-stage study
June 18, 2015 at 17:59 PM EDT
June 18 (Reuters) - Amgen Inc said its drug met the main goal of improving overall survival in metastatic colorectal cancer patients who have not responded to chemotherapy.
